Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia

被引：118

作者：

Oscier, David ^{[1
]}

Dearden, Claire ^{[2
]}

Erem, Efrem ^{[3
]}

Fegan, Christopher ^{[4
]}

Follows, George ^{[5
]}

Hillmen, Peter ^{[6
]}

Illidge, Tim ^{[7
]}

Matutes, Estella ^{[2
]}

Milligan, Don W. ^{[8
]}

Pettitt, Andrew ^{[9
]}

Schuh, Anna ^{[10
]}

Wimperis, Jennifer ^{[11
]}

机构：

[1] Royal Bournemouth Hosp, Bournemouth, Dorset, England

[2] Royal Marsden Hosp, London SW3 6JJ, England

[3] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England

[4] Cardiff & Vale NHS Trust, Cardiff, S Glam, Wales

[5] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England

[6] St Jamess Inst Oncol, Leeds, W Yorkshire, England

[7] Christie Hosp NHS Trust, Manchester M20 4BX, Lancs, England

[8] Heart England NHS Foundata Trust, Birmingham, W Midlands, England

[9] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England

[10] Churchill Hosp, Oxford OX3 7LJ, England

[11] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 159卷 / 05期

关键词：

chronic lymphocytic leukaemia; small lymphocytic lymphoma; guideline; STEM-CELL TRANSPLANTATION; FLUDARABINE PLUS CYCLOPHOSPHAMIDE; HIGH-DOSE METHYLPREDNISOLONE; PHASE-II TRIAL; PREVIOUSLY UNTREATED PATIENTS; AUTOIMMUNE HEMOLYTIC-ANEMIA; PROGRESSION-FREE SURVIVAL; MINIMAL RESIDUAL DISEASE; QUALITY-OF-LIFE; LRF CLL4 TRIAL;

D O I：

10.1111/bjh.12067

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：541 / 564

页数：24

共 181 条

[1]

[Anonymous], 1999, J Natl Cancer Inst, V91, P861

[2]

[Anonymous], BLOOD

[3]

[Anonymous], ASH ANN M

[4]

[Anonymous], BLOOD

[5] American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases [J].

Artz, Andrew S. ;

Somerfield, Mark R. ;

Feld, Jordan J. ;

Giusti, Andrew F. ;

Kramer, Barnett S. ;

Sabichi, Anita L. ;

Zon, Robin T. ;

Wong, Sandra L. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) :3199-3202

[6] Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia [J].

Badoux, Xavier C. ;

Keating, Michael J. ;

Wang, Xuemei ;

O'Brien, Susan M. ;

Ferrajoli, Alessandra ;

Faderl, Stefan ;

Burger, Jan ;

Koller, Charles ;

Lerner, Susan ;

Kantarjian, Hagop ;

Wierda, William G. .

BLOOD, 2011, 118 (08) :2085-2093

[7]

Bayrakci B, 2005, TURKISH J PEDIATR, V47, P239

[8] Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10 [J].

Bene, M. C. ;

Nebe, T. ;

Bettelheim, P. ;

Buldini, B. ;

Bumbea, H. ;

Kern, W. ;

Lacombe, F. ;

Lemez, P. ;

Marinov, I. ;

Matutes, E. ;

Maynadie, M. ;

Oelschlagel, U. ;

Orfao, A. ;

Schabath, R. ;

Solenthaler, M. ;

Tschurtschenthaler, G. ;

Vladareanu, A. M. ;

Zini, G. ;

Faure, G. C. ;

Porwit, A. .

LEUKEMIA, 2011, 25 (04) :567-574

[9] A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease [J].

Best, O. G. ;

Gardiner, A. C. ;

Davis, Z. A. ;

Tracy, I. ;

Ibbotson, R. E. ;

Majid, A. ;

Dyer, M. J. S. ;

Oscier, D. G. .

LEUKEMIA, 2009, 23 (01) :212-214

[10]

BHIV, 2008, GUID HIV TEST 2008

← 1 2 3 4 5 6 7 8 9 10 →